Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Dr. Heba Abdelmegeed, National Research Centre, Egypt

Dr. Heba Abdelmegeed is a senior researcher at the Chemistry of Natural Compounds Department, National Research Centre, Cairo, Egypt. 🎓 She earned her Ph.D. in Immunology (Magna Cum Laude) from Technische Universität Dresden, Germany, and a Master’s in Pharmaceutical Sciences from Hokkaido University, Japan. With expertise in immunology, molecular biology, and cancer biology, she has authored impactful research on cancer therapeutics and immunomodulation. 🧪 Her diverse academic journey spans Germany, Japan, and Egypt, with multiple publications, awards, and international conference contributions. Driven by scientific curiosity, she continues to explore cutting-edge innovations in cancer biology and immunological research.

Publication Profile

Google Scholar

Education

Dr. Heba Abdelmegeed is a distinguished immunologist with a rich academic journey across three continents. She earned her Ph.D. in Immunology (magna cum laude) from the Technische Universität Dresden, Germany 🇩🇪, where her research focused on the activation-dependent rearrangement of macrophage lipid metabolism. Prior to that, she completed her M.Sc. in Pharmaceutical Sciences at Hokkaido University, Japan 🇯🇵, exploring innovative approaches to activate iNKT cells using α-GalCer liposomes and interleukin 12. Her academic path began in Egypt 🇪🇬, graduating with honors from Ain Shams University with a Bachelor’s in Pharmaceutical Sciences.

Experience

Dr. Heba Abdelmegeed is a dedicated researcher with a diverse and global professional background in pharmaceutical sciences. Since August 2020, she has served as a Senior Researcher at the Chemistry of Natural Compounds Department, NRC, Egypt 🇪🇬. Previously, she was a Ph.D. candidate at the Technical University of Dresden, Germany 🇩🇪, from 2015 to 2020. She also held the role of Assistant Researcher at NRC and was a Master’s candidate at Hokkaido University, Japan 🇯🇵. Her career began as a Quality Control Analyst at NODCAR, reflecting her strong foundation in drug analysis and research.

Research Focus

Dr. Heba Abdelmegeed’s research primarily focuses on pharmacology, medicinal chemistry, and cancer biology 🧪🔬. Her work includes developing novel anti-cancer compounds, such as quinoline and pyridine derivatives, targeting tubulin polymerization and cyclin-dependent kinases to inhibit tumor growth 🎯💊. She also explores nanoparticle drug delivery systems for enhanced antimicrobial and wound healing effects 🧫🩹. Additionally, Dr. Abdelmegeed investigates inflammation, mitochondrial function, and lipid metabolism in cancer and endocrine disorders 🔥🦠⚙️. Her multidisciplinary approach bridges molecular biology, synthetic chemistry, and computational studies to advance therapeutic strategies against cancer and infectious diseases.

Publication Top Notes

In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide–Loaded Liposomes and …

Succinate mediates inflammation-induced adrenocortical dysfunction

Coumarins: quorum sensing and biofilm formation inhibition

New heterocycles from dehydroacetic acid (DHA). Synthesis, antimicrobial activity, DNA gyrase inhibition, antioxidant activity, and molecular docking study

Chitosan nanoparticles of new chromone-based sulfonamide derivatives as effective anti-microbial matrix for wound healing acceleration

Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer

Obesity-associated lipidomic remodeling of the adrenal gland indicates an important role of the FADS2-arachidonic acid axis in adrenocortical hormone production

INFLAMMATION–INDUCED DOWNREGULATION OF SUCCINATE DEHYDROGENASE REGULATES ADRENOCORTICAL FUNCTION

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking

Mitochondria in cancer: a comprehensive review, bibliometric analysis, and future perspectives

Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award  

Mrs. Akhlesh Kumari, IFTM University Moradabad, India

Mrs. Akhlesh Kumari 📚👩‍🎓 is a dedicated academician with 8 years of teaching experience and pursuing Ph.D. in Pharmaceutical Chemistry 📊. With an M. Pharm from Central University, Rajasthan 🎓, she has published 4 research papers 📄 and filed 3 patents 📝. Her research focuses on Pharmaceutical Chemistry 🔬, contributing to the field’s advancement. Mrs. Kumari’s commitment to education and research makes her a promising figure in her field 🌟. With a citation index of 13 📈, she demonstrates her impact on the research community. Her work showcases her potential as a leading researcher 🔍.

Publication Profile

Google Scholar 

Education

Mrs. Akhlesh Kumari is a dedicated academician with a strong background in pharmaceutical sciences 📚. With 8 years of teaching experience 📝, she has established herself as a knowledgeable educator. Currently, she is pursuing her Ph.D. from IFTM University, Moradabad, India 🎓, further enhancing her expertise. She holds an M. Pharm degree in Pharmaceutical Chemistry from Central University, Rajasthan, India 🏫. Her academic pursuits demonstrate her commitment to advancing knowledge in her field 🔬. With a passion for teaching and research, Mrs. Kumari is poised to make significant contributions to pharmaceutical sciences.

Professional Memberships

Mrs. Akhlesh Kumari’s professional affiliations are currently focused on her academic and research pursuits 📚. Although she doesn’t hold any specific professional memberships 🤝, her dedication to her field is evident through her teaching and research endeavors. As she continues to grow in her career, potential memberships in professional organizations could further enhance her networking opportunities and contributions to pharmaceutical sciences 🌐. For now, her commitment to education and research remains a priority, driving her to make meaningful impacts in her field 🔬.

Research Focus

Mrs. Akhlesh Kumari focuses her research on organic synthesis, particularly the development of heterocyclic compounds and transition metal-catalyzed reactions such as Ruthenium-catalyzed oxidative annulation. Her work explores the design of novel antimicrobial agents, including thymol-derived chalcones and benzotriazoles, integrating computational studies to understand structure-activity relationships. This research is crucial in the development of new pharmaceutical compounds with potential biological activity. Her studies bridge synthetic organic chemistry and medicinal chemistry, targeting antimicrobial resistance and innovative drug discovery strategies.

Publication Top Notes

Ruthenium‐catalyzed oxidative annulation of anilines using benzothiazole as a removable directing group

Synthesis, computational studies of new thymol derived chalcones and their benzotriazoles as antimicrobial agents

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Yan Zhang | Medicinal Chemistry | Best Researcher Award  

Assoc. Prof. Dr. Yan Zhang, Hospital of Stomatology, Jilin University, China

Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, specializing in innovative dental implant materials, particularly magnesium-based alloys. She is currently a researcher at the Hospital of Stomatology, Jilin University, focusing on biocompatible implant development. With over 10 SCI-indexed publications, her work on the Nd-modified alloy ZNdK610 shows enhanced osteogenic potential. Dr. Zhang has completed three research projects and is actively pursuing translational research and industry collaborations. Though she has no patents or books yet, her pioneering research continues to push boundaries in implant material science.

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, with a research focus on innovative implant materials, particularly the application of magnesium alloys 🧪🦷. As a dedicated researcher at the Hospital of Stomatology, Jilin University, Dr. Zhang is actively involved in developing biocompatible materials to improve dental implant performance. Her work aims to enhance osseointegration and long-term implant success through advanced biomaterials 🔬💡. With over 10 SCI-indexed publications, she has significantly contributed to the field of dental biomaterials, driving progress in implant technology and patient care 📚👩‍⚕️.

Professional Memberships

Assoc. Prof. Dr. Yan Zhang is currently not affiliated with any professional memberships or academic societies ❌📋. Despite this, her dedication to advancing dental implant technology through independent research remains unwavering 🔬🦷. Her work at the Hospital of Stomatology, Jilin University, continues to make meaningful contributions to the field, particularly in the development of magnesium alloy-based implant materials ⚙️🧪. While she may not hold formal memberships, her impactful research, numerous SCI-indexed publications, and commitment to scientific innovation speak volumes about her professional standing and influence in the stomatology community 📖💼.

Research Focus

Assoc. Prof. Dr. Yan Zhang specializes in Periodontal Regeneration and Tissue Engineering. Their research primarily focuses on how biological factors like Concentrated Growth Factor (CGF) exudate influence the healing and proliferation of human periodontal ligament cells, especially under inflammatory conditions such as those involving TNF-α (tumor necrosis factor-alpha). This work is crucial in understanding and improving treatments for periodontal diseases by promoting tissue repair and regeneration. Dr. Zhang’s research bridges cell biology, inflammation, and regenerative medicine to develop innovative therapies for oral health.

Publication Top Notes

Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-α

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Posted on by sciencefather

Surya Nandan Meena | Drug Discovery and Development | Best Researcher Award

Dr. Surya Nandan Meena, Savitribai Phule Pune University, India

Dr. Surya Nandan Meena is an accomplished researcher in natural product chemistry with over 7 years of postdoctoral experience. He has authored 16 peer-reviewed publications, 4 books, and 8 book chapters, focusing on anticancer and antidiabetic compound discovery. 🧬 His expertise spans LC-MS/MS, molecular docking, and mammalian cell assays. 🎓 A recipient of prestigious fellowships like the Dr. D.S. Kothari and SERB-DST, he has led international projects, mentored students, and contributed to multidisciplinary science globally. 🌱 Passionate about drug discovery and marine biotechnology, Dr. Meena actively serves on editorial boards and scientific societies worldwide.

Publication Profile

Google Scholar

Education

Dr. Surya Nandan Meena is a dedicated scholar with a robust academic background in biotechnology and agriculture. He earned his Ph.D. in Biotechnology from Goa University, India (Nov 2010 – April 2017), where he conducted extensive research in the field. Prior to that, he completed his M.Sc. in Plant Biotechnology from UAS Dharwad, India (July 2006 – April 2009), further refining his expertise in plant sciences 🌿. His academic journey began with a B.Sc. (Hons) in Agriculture from MPUAT, Udaipur, Rajasthan (July 2002 – June 2006) 🌾, laying a strong foundation for his future contributions to agricultural biotechnology.

Awards

Dr. Surya Nandan Meena has been honored with numerous prestigious awards and research fellowships throughout his academic journey. In 2019, he received the Kothari Postdoctoral Research Fellowship from UGC, India. He earned the Best Research Paper Appreciation Award from Anchrome Pvt. Ltd. in 2018 📜. In 2017, he was awarded the National Postdoctoral Fellowship by SERB-DST, India. His dedication was also recognized with the Senior Research Fellowship from DBT in 2013 and the Best Poster Presentation Award in 2012 🧪. Earlier, he secured the Junior Research Fellowship from DBT in 2009 and the JNU CEEB Fellowship in 2006 🎓.

Experience

Dr. Surya Nandan Meena brings a wealth of professional experience in biotechnology and marine research. Since Nov 2019, he has served as a Postdoctoral Fellow at Pune University, conducting mammalian cell-based assays and characterizing bioactive seaweed compounds 🌊. Earlier, at the National Institute of Oceanography (2017–2019), he surveyed 35+ seaweed species and contributed to multiple publications 📚. As a Senior Research Fellow at ICAR-CCARI (2016–2017), he identified beneficial microbial strains 🌱 and developed plant growth formulations. His roles also included mentoring students, publishing in high-impact journals, and leading interdisciplinary research, reflecting his dedication to scientific innovation and collaboration 👨‍🔬.

Research Focus

Dr. Surya Nandan Meena’s research centers on natural product chemistry, sustainable bioresource utilization, and drug discovery. His work bridges the gap between marine and terrestrial natural compounds for therapeutic applications, especially targeting antidiabetic, antioxidant, and anticancer properties. With notable contributions in biocatalysis, phytochemistry, and biosynthetic pathways, Dr. Meena emphasizes green, solvent-free synthesis and eco-friendly resource management. He actively explores seaweed farming, plant-based compounds, and essential oils as potent sources for novel bioactives. His multidisciplinary approach contributes significantly to natural compound-based drug development and sustainable healthcare innovation.

Publication Top Notes

Natural resources conservation and advances for sustainability

Graphite catalyzed solvent free synthesis of dihydropyrimidin-2 (1H)-ones/thiones and their antidiabetic activity

Seaweed Farming: A Perspective of Sustainable Agriculture and Socio-economic Development

Advances in Biological Science Research: A Practical Approach

Biosynthesis of vanillic acid by Ochrobactrum anthropi and its applications

α-Glucosidase inhibition activity and in silico study of 2-(benzo [d][1, 3] dioxol-5-yl)-4H-chromen-4-one, a synthetic derivative of flavone

Quick Identification of Piperidine Alkaloid from Roots of Grewia nervosa and Their Glucosidase Inhibitory Activity

Antioxidant and antiglycemic properties of macroalgae, an underutilized blue economy bioresource in India

Evaluation of silver-doped indium oxide nanoparticles as in vitro α-amylase and α-glucosidase inhibitors

New horizons in natural compound research

Biodegradation of seafood waste by seaweed-associated bacteria and application of seafood waste for ethanol production

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Posted on by sciencefather

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Dr. TRAN CHAUMYTHANH, DUYTAN UNIVERSITY, Vietnam

Dr. Chaumy Thanh Tran is a dedicated medical doctor and Ph.D. holder from Hue University of Medicine and Pharmacy, Vietnam. Her groundbreaking research integrates online medical databases and sequencing technologies to explore biomarkers for early disease detection—including diabetes, cardiovascular diseases, stroke, and cancers. She focuses on gene-targeted drug development and CRISPR/Cas9 gene editing. From 2023 to 2025, her work on LncRNA/CircRNA/miRNA/gene/protein-drug networks stands out as a vital resource for molecular biology. With several publications in high-impact journals (SCI, Scopus), Dr. Tran’s innovations aim to elevate human health and therapeutic strategies worldwide.

Publication Profile

Scopus

Education

Dr. Tran Chaumythanh 🎓 is a dedicated medical professional with a strong academic foundation in medicine. She earned her Medical Doctor (MD) degree from Hue University of Medicine and Pharmacy, Vietnam 🏥, where she also pursued and completed her Doctorate (Ph.D.) in the same esteemed institution 📚. With a commitment to advancing healthcare and medical education, Dr. Chaumythanh combines clinical expertise with academic excellence, contributing to both patient care and research innovation. Her journey reflects a passion for medicine and a continuous drive for knowledge, shaping her as a respected figure in Vietnam’s medical and academic communities 🌟.

Research Experience

Dr. Tran Chaumythanh 🔬 is at the forefront of cutting-edge research in molecular biology, leveraging online medical databases and next-generation sequencing technologies to advance modern disease studies. Her work focuses on identifying early biomarkers 🧬 for diabetes, cardiovascular diseases, strokes, and cancers. She also explores gene targets for novel drug development 💊 and utilizes gene-editing tools like CRISPR/Cas9 to correct harmful mutations 🧪. From 2023 to 2025, her investigations delve into the complex interaction networks of LncRNA, CircRNA, miRNA, genes, and proteins, aiming to build a comprehensive knowledge base for future therapeutic innovations and precision medicine 🔗📈.

Research Focus

Dr. Tran ChaumyThanh’s research primarily centers on bioinformatics-driven analysis of latent tuberculosis (TB), with a strong focus on gene and miRNA regulatory networks, immune cell infiltration, and potential drug-gene interactions. Utilizing microarray data analysis, molecular docking, and molecular dynamics simulation, her work aims to identify novel therapeutic targets and unravel complex host-pathogen interactions. This multidisciplinary approach bridges computational biology, immunology, and pharmacology, contributing to precision medicine and effective TB management. 🧪📊🧠 Her research holds promise for developing targeted therapies and improving our understanding of latent TB immune mechanisms.

Publication Top Notes

Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

Minglong Yan | Drug Discovery and Development | Young Scientist Award

Posted on by sciencefather

Minglong Yan | Drug Discovery and Development | Young Scientist Award

Mr. Minglong Yan, Chinese Academy of Science, China

Mr. Minglong Yan holds advanced degrees in his field, with a distinguished academic and professional background in scientific research and innovation. He has completed multiple research projects, contributed to numerous indexed journal publications, and holds editorial appointments in reputable journals. With a strong citation index in SCI and Scopus, he is actively engaged in industry-sponsored projects, collaborative studies, and has authored several ISBN-registered books 📚. His expertise spans diverse research areas, contributing significantly to scientific advancement and innovation, including patents published or in process. Mr. Yan is also a member of esteemed professional organizations, fostering academic excellence globally 🌐.

Publication Profile

orcid

Education

Mr. Minglong Yan 🎓 holds advanced degrees in engineering and materials science, with a strong foundation in innovative research and development. With over a decade of professional experience, he has contributed significantly to the fields of advanced materials and nanotechnology. 🧪 His work has been recognized in peer-reviewed journals and international conferences. As a dedicated academic, he has mentored numerous students and collaborated on global research initiatives. 🌏 Mr. Yan’s achievements include multiple research grants and awards that highlight his impactful contributions to science and technology. 🔬 His commitment to excellence continues to inspire innovation and academic advancement.

Experience

Mr. Minglong Yan 🤝 has built strong interdisciplinary collaborations with researchers from institutions across various countries, fostering global scientific exchange and innovation. 🌐 His collaborative efforts have led to numerous joint publications, international workshops, and the development of data-sharing platforms 📊 that enhance research transparency and accessibility. Notably, his work on a multi-institutional study focused on advanced nanomaterials 🧬 gained considerable recognition within the research community, showcasing the power of international teamwork. These partnerships not only broaden the impact of his research but also contribute to the advancement of science through shared knowledge and collective expertise.

Professional Memberships

Mr. Minglong Yan 🧑‍🔬 is an active member of the IEEE ⚙️ and the Materials Research Society (MRS) 🔬, two prestigious organizations that support scientific innovation and collaboration. Through these memberships, he engages with leading experts in his field, stays updated on emerging research trends 📈, and participates in global conferences and symposiums 🌍. These affiliations provide valuable platforms for networking, professional development, and interdisciplinary exchange. Mr. Yan’s involvement in such renowned societies highlights his dedication to advancing science and technology while remaining connected to the broader research community.

Research Focus

Mr. Minglong Yan focuses on smart surface engineering, particularly the development of anti-biofouling materials, self-healing coatings, and slippery lubricant-infused surfaces (SLIPS). His research merges materials science, nanotechnology, and green chemistry to design photocatalytic, self-renewable, and multi-functional coatings. These materials aim to resist microbial adhesion and environmental fouling, with long-term durability and ecological safety. His work is especially impactful in marine applications, medical devices, and membrane technology. 🧪🦠💧🔄⚙️ His innovative use of Schiff-base chemistry, MOFs, organogels, and paraffin frameworks pushes boundaries in dynamic surface behavior and bio-inspired antifouling strategies.

Publication Top Notes

Designing a photocatalytic and self-renewed g-C3N4 nanosheet/poly-Schiff base composite coating towards long-term biofouling resistance

Cinnamaldehyde grafted porous Aerogel-Organ gel liquid infused surface for achieving difunctional long-term dynamic antifouling

Multi-stimulus Response Behavior of Biomimetic Autocrine Waxy Materials for Potential Self-Constructing Surface Microstructures

Antibacterial-renew dual-function anti-biofouling strategy: Self-assembled Schiff-base metal complex coatings built from natural products

Foaming process-induced porous silicone-based organogel for low biofouling adhesion with improved long-term stability

Cross‐Linked but Self‐Healing and Entirely Degradable Poly‐Schiff Base Metal Complex Materials for Potential Anti‐Biofouling

Designing a MOF-based slippery lubricant-infused porous surface with dual functional anti-fouling strategy

Salih PAŞA | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Salih PAŞA | Pharmaceutical Chemistry | Best Researcher Award

Assoc. Prof. Dr Salih PAŞA, Afyon Kocatepe University, Turkey

Assoc. Prof. Dr. Salih PAŞA is an esteemed inorganic chemist specializing in pharmaceutical chemistry, anticancer research, and catalytic investigations. He earned his BSc (2007), MSc (2010), and PhD (2014) in Inorganic Chemistry. With extensive expertise in boron compounds, biodegradable polymers, and spectroscopy techniques, he has significantly contributed to Schiff base ligand coordination chemistry and Suzuki coupling reactions. Currently, he serves at Afyon Kocatepe University, Turkey. His pioneering work on boron-based cancer therapeutics and water purification underscores his impactful research.

Publication Profile

google scholar

Education

Assoc. Prof. Dr. Salih Paşa 🎓 has built a strong academic foundation in chemistry, specializing in inorganic chemistry. He earned his Bachelor of Science (BSc) degree in Chemistry (2002-2007) 🧪, followed by a Master of Science (MSc) in Inorganic Chemistry (2007-2010) ⚗️. His passion for research and scientific exploration led him to pursue a PhD in Inorganic Chemistry (2010-2014) 🔬. Through years of dedication, he has contributed significantly to the field, advancing knowledge in chemical sciences. His academic journey reflects a commitment to excellence, making valuable contributions to research and education in inorganic chemistry. 📚✨

Research Interest

Assoc. Prof. Dr. Salih Paşa 🔬 focuses his research on the coordination chemistry of polydentate ligands, particularly thio Schiff bases and their transition metal complexes. His work explores their analytical applications, synthetic utility, and biological activity 🧪. He is especially interested in palladium complexes of (N,O,S) and (N,O,P) type ligands, known for their catalytic role in Suzuki coupling reactions ⚗️. Additionally, he investigates boronic acids, unique boron-based compounds that act as Lewis acids, forming reversible covalent bonds with sugars, amino acids, and other Lewis base donors. His studies contribute significantly to advancing inorganic and organometallic chemistry. 🌟

Instrumental Expertise

Assoc. Prof. Dr. Salih Paşa 🎓 possesses extensive expertise in advanced analytical instrumentation, crucial for modern chemical research. He is highly skilled in techniques such as LC-MS/MS, NMR (¹³C & ¹H), XRD, SEM, FTIR, UV-Vis, AAS, GC, and thermal analysis 🔬⚗️. His proficiency in single-crystal X-ray diffraction studies allows for precise molecular structure determination, enhancing the understanding of complex chemical compounds 🧪. With a strong command of these instrumental techniques, he contributes significantly to inorganic and materials chemistry, facilitating groundbreaking research in coordination chemistry, catalysis, and boron-based compounds. His expertise ensures high precision in chemical analysis.

Future Potential

Assoc. Prof. Dr. Salih Paşa 🌱🔬 is actively exploring innovative research in sustainable chemistry and materials science. His recent work focuses on developing biodegradable polymer materials from waste potato starch, contributing to green chemistry and environmental sustainability 🌍♻️. Additionally, his research on the polymerization of Schiff base ligands opens new possibilities in advanced materials, with potential applications in catalysis, drug delivery, and nanotechnology ⚗️. Through his dedication to eco-friendly solutions and cutting-edge polymer research, he aims to revolutionize materials science, creating sustainable alternatives that benefit both industry and the environment. His work paves the way for a greener future. 🌟

Scientific Recognition

Assoc. Prof. Dr. Salih Paşa 📚🔬 has earned significant scientific recognition through multiple publications in high-impact SCI journals, including Chinese Chemical Letters, Inorganica Chimica Acta, Polyhedron, Applied Catalysis A, Applied Organometallic Chemistry, and Tetrahedron: Asymmetry 🏆. His collaborations with international researchers, particularly from Kazakh-British Technical University, highlight his global academic influence 🌍🤝. His contributions to catalysis, drug discovery, and polymer chemistry reinforce the importance of his research, driving advancements in these fields. Through his dedication and impactful studies, he continues to shape the future of inorganic and organometallic chemistry. ⚗️✨

Research Focus

Assoc. Prof. Dr. Salih Paşa’s research primarily focuses on green chemistry 🌱, nanotechnology 🧪, and materials science 🏗️. His work includes the green synthesis of nanoparticles ⚛️, biodegradable materials for eco-friendly applications 🌍, and catalysis in organic synthesis 🔬. He has contributed significantly to biodegradable food packaging 🍽️, anticancer drug discovery 🏥, and advanced polymer materials 🏭. His studies on Schiff bases 🧬, metal complexes ⚗️, and biocompatible materials 🔄 highlight his expertise in designing sustainable and functional materials with industrial and biomedical applications. His work aligns with pharmaceutical chemistry 💊, material engineering 🏢, and green nanotechnology 🌿.

Publication Top Notes

Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: The characterization, anticancer potential with photodynamic therapy in MCF7 cells

The fabrication of bilayer polylactic acid films from cross-linked starch as eco-friendly biodegradable materials: synthesis, characterization, mechanical and physical properties

Silane doped biodegradable starch-PLA bilayer films for food packaging applications: Mechanical, thermal, barrier and biodegradability properties

Synthesis, characterization and catalytic behavior in the Suzuki reaction of Schiff base and its complexes and the optical properties of nickel complex used in the fabrication …

Flavonoids from Sideritis Species: Human Monoamine Oxidase (hMAO) Inhibitory Activities, Molecular Docking Studies and Crystal Structure of Xanthomicrol

Synthesis, characterization, electrochemical behaviors and applications in the Suzuki–Miyaura cross-coupling reactions of N2S2O2 thio Schiff base ligand and its Cu (II), Co …

Physicochemical properties for food packaging and toxicity behaviors against healthy cells of environmentally friendly biocompatible starch/citric acid/polyvinyl alcohol …

The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities

Structural investigation of raw clinoptilolite over the Pb2+ adsorption process from phosphoric acid

Zeynep Kalaycıoğlu | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Zeynep Kalaycıoğlu | Pharmaceutical Chemistry | Best Researcher Award

Assoc. Prof. Dr Zeynep Kalaycıoğlu, Istanbul Technical University, Turkey

Assoc. Prof. Dr. Zeynep Kalaycıoğlu is a distinguished researcher and lecturer at Istanbul Technical University 🏛️, specializing in analytical chemistry 🧪. Her expertise spans metal/metal oxide nanoparticle synthesis, drug-protein interactions, and biopolymeric composite films for food packaging and wound dressing 🌱. With over 30 high-impact publications 📄, two book chapters 📚, and multiple research projects, she has significantly contributed to multidisciplinary collaborations in materials science, biochemistry, and pharmaceutical sciences 🏆. Currently, she leads a funded project on green synthesis of bioactive nanoparticles from olive mill wastewater 🌿, promoting sustainability in scientific innovation. 🚀

Publication Profile

Scopus

Professional Background

Assoc. Prof. Dr. Zeynep Kalaycıoğlu is an academic researcher and lecturer at Istanbul Technical University, specializing in analytical chemistry 🔬. Her Ph.D. focused on isolating and characterizing bioactive compounds from natural products 🌿, developing advanced analytical techniques, and exploring biopolymer applications. With extensive experience in teaching analytical chemistry labs 🏫, she has guided students through complex experimental techniques. Her research interests span metal/metal oxide nanoparticle synthesis ⚛️, drug-protein interactions 💊, and biopolymeric composite films. Dr. Kalaycıoğlu collaborates with multidisciplinary teams across materials science, biochemistry, and pharmaceutical sciences, contributing to cutting-edge advancements in her field 🔍.

Professional Memberships

Assoc. Prof. Dr. Zeynep Kalaycıoğlu is a dedicated member of the Turkish Chemical Society ⚗️ and an expert in analytical chemistry 🔬. Her research focuses on metal/metal oxide nanoparticle synthesis ⚛️, drug-protein interactions 💊, and biopolymeric composite films for food packaging 🥫 and wound dressing 🩹. She also specializes in capillary electrophoresis, statistical analysis 📊, food analysis 🍎, and water remediation 💧. Additionally, her work involves molecular docking 🧬 to explore chemical interactions at the molecular level. Through her multidisciplinary research, Dr. Kalaycıoğlu continues to contribute innovative solutions to chemistry, materials science, and pharmaceutical applications.

Academic Research

Assoc. Prof. Dr. Zeynep Kalaycıoğlu actively shares her research through various academic platforms 🌐. Her profiles on Google Scholar 📚, ResearchGate 🔬, and LinkedIn 💼 showcase her contributions to analytical chemistry and multidisciplinary studies. These platforms highlight her publications, collaborations, and scientific impact. Additionally, she maintains a repository of relevant ID and certification documents 🏆, ensuring transparency and credibility in her academic journey. By engaging with global researchers and institutions, Dr. Kalaycıoğlu continues to advance knowledge in nanoparticle synthesis, drug-protein interactions, and biopolymeric applications, making significant contributions to science and technology.

Awards

Assoc. Prof. Dr. Zeynep Kalaycıoğlu is honored to be considered for prestigious scientific awards 🏆. With her extensive contributions to analytical chemistry, nanoparticle synthesis ⚛️, and biopolymeric applications 🌿, she aligns with categories such as the Distinguished Scientist Award, Outstanding Scientist Award, and Excellence in Research 🔬. As a dedicated educator and innovator, she also qualifies for the Best Faculty Award 🎓 and Best Innovation Award 💡. Passionate about advancing science and mentoring future researchers, she seeks recognition that reflects her commitment to groundbreaking discoveries and impactful contributions to multidisciplinary research.

Research Focus

Assoc. Prof. Dr. Zeynep Kalaycıoğlu’s research primarily focuses on biophysical chemistry 🧪, particularly the interaction of biomolecules 🧬 with pharmaceutical and polymeric compounds. Her work spans protein-ligand binding 🔬, spectroscopic characterization 📊, and molecular docking analysis 🖥️ to understand biochemical interactions at a molecular level. She also explores nanomaterials ⚛️ for biomedical applications, including wound healing hydrogels 🩹 and drug delivery systems 💊. Her expertise in capillary electrophoresis ⚡ further enhances the understanding of biomolecular interactions. Through her interdisciplinary approach, she contributes to advancements in biomedical engineering 🏥, materials science 🏗️, and pharmaceutical research 🌱.

Publication Top Notes

Binding interaction between sodium carboxymethyl cellulose and serum albumin: Insights from multi-spectroscopy methods, rheological characterization and molecular docking analysis

Foam-based antibacterial hydrogel composed of carboxymethyl cellulose/polyvinyl alcohol/cerium oxide nanoparticles for potential wound dressing

Capillary Electrophoresis-Frontal Analysis (CE-FA) and Molecular Docking Studies on the Albumin-Binding Properties of Dopamine and Serotonin

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Posted on by sciencefather

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Dr Hui Xiao,regeneron,United States

Dr. Hui Xiao 🧪🔬 is a distinguished scientist specializing in biochemistry, structural biology, and mass spectrometry. With a strong focus on microtubule dynamics, protein interactions, and drug mechanisms, he has made significant contributions to understanding cellular processes. As a co-first author and lead researcher, his work has been published in esteemed journals like J. Mol. Biol., Biochemistry, and J. Biol. Chem.. His expertise spans hydrogen-deuterium exchange, proteomics, and molecular stabilization studies. Dr. Xiao’s research has advanced drug discovery, particularly in cancer therapeutics and protein biochemistry. 📚🔍 His innovative approaches continue to impact biomedical sciences globally. 🌍✨

Publication Profile

Scopus

Education

Dr. Hui Xiao 🎓 holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst (2005) and a degree in Applied Chemistry from Peking University, China (1992). Currently serving as an Associate Director at Regeneron Pharmaceuticals 🏢, he specializes in protein characterization using mass spectrometry. With over a decade at Regeneron, he has progressed through roles as a Senior Staff Scientist and Staff Scientist. Previously, he held academic positions at Albert Einstein College of Medicine 🧬, advancing from Instructor to Research Associate Professor. His expertise spans analytical chemistry, protein analysis, and therapeutic protein research, making significant contributions to biomedical science. 🔬

Professional Impact

Dr. Hui Xiao 🎓 is a distinguished scientist with over 20 years of experience in academia and the biotechnology industry. Currently, he serves as an Associate Director of Analytical Chemistry at Regeneron Pharmaceuticals 🏢, a leading biotech company. His expertise lies in mass spectrometry applications for protein characterization 🔬, contributing to advancements in therapeutic development. Before joining Regeneron, Dr. Xiao held esteemed faculty positions at Albert Einstein College of Medicine 🧬, progressing from Instructor to Research Associate Professor. His extensive research and leadership have played a crucial role in bridging analytical chemistry with biopharmaceutical innovation, impacting drug discovery and development. 🚀

Scientific Contributions

Dr. Hui Xiao 🎓 is a leading expert in protein-ligand interactions, structural proteomics, and therapeutic protein analysis 🔬. His pioneering work includes the application of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for epitope mapping 🧩 and microtubule stabilization research. With a deep focus on drug characterization and regulatory sciences, his contributions have significantly advanced biopharmaceutical development 💊. His expertise in mass spectrometry-driven protein analysis has helped enhance the understanding of molecular mechanisms, improving therapeutic strategies. Through innovation and research, Dr. Xiao continues to play a vital role in shaping the future of biopharmaceutical science and drug discovery. 🚀

Potential Considerations

Dr. Hui Xiao 🎓 is a renowned expert in analytical and protein chemistry, with groundbreaking work in epitope mapping and protein characterization 🔬. While his contributions significantly impact drug development, the Pharmaceutical Innovation Achievement Award 🏆 may prioritize direct advancements in drug discovery and novel pharmaceutical interventions 💊. His research has important regulatory and therapeutic implications, but highlighting specific drug innovations or regulatory breakthroughs he has led would further strengthen his case. By showcasing his role in pioneering pharmaceutical advancements, Dr. Xiao’s influence in shaping modern biopharmaceutical science can be fully recognized and appreciated. 🚀

Research Focus

Dr. Hui Xiao’s research primarily focuses on analytical chemistry 🧪, particularly in the quantitative analysis of biomolecules 🧬 using advanced mass spectrometry techniques ⚖️. His work involves CRISPR sgRNA modification analysis 🧬🔬 and the development of LC-MS-based assays for biological therapeutics 💊. He specializes in phosphorothioate isomer detection 🔄 and liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) 📊 for precise biomolecular quantification. His contributions are crucial in drug discovery 🏥, gene editing 🧬, and biopharmaceutical development 💉. His expertise bridges biotechnology 🔬 and analytical methodologies 📈, advancing innovations in therapeutic monitoring and molecular diagnostics 🏥.

Publication Top Notes

Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)

Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum

Ala Hssain | Drug Discovery and Development | Best Researcher Award

Posted on by sciencefather

Ala Hssain | Drug Discovery and Development | Best Researcher Award

Ms Ala Hssain,University of Halabja,Iraq

Dr. Ala Hamd Hssain 🇮🇶 is a dedicated physicist specializing in material science and quantum mechanics. She earned her PhD in Material Science (2023) from Firat University, Turkey, and her Master’s in Quantum Mechanics (2014) from Eastern Mediterranean University, Cyprus. Currently, she is a faculty member at University of Halabja, Iraq, teaching quantum mechanics and advanced calculus. Her research focuses on DFT simulations, molecular modeling, and hydroxyapatite materials, with numerous publications in high-impact journals 📚. Proficient in Gaussian, Vesta, and Multiwfn, she actively contributes to scientific advancements in computational and experimental physics. ✨

Publication Profile

Scopus

Education

Ms. Ala Hssain 🎓 earned her Ph.D. in Material Science (2019-2023) from Firat University, Faculty of Science, Physics Department, in Elazig, Turkey 🇹🇷. She previously completed her Master’s degree in Quantum Mechanics (2012-2014) at Eastern Mediterranean University, Cyprus 🇨🇾, under the supervision of Prof. Dr. Habib Mazharimousavi. Her academic journey began with a Bachelor’s degree in Physics from Salahaddin University 🎓. With a strong foundation in physics and material science, she has dedicated her research to advancing knowledge in these fields, contributing to cutting-edge developments in quantum mechanics and material engineering. ⚛️🔬

Academic Experience

Ms. Ala Hssain 🎓 has a rich background in teaching and laboratory assistance. She served as an assistant physicist at the University of Sulaimani 🔬, working in optics, electricity, and measurement labs (2009-2010), solid-state and atomic labs (2010-2011), and atomic labs (2011-2012). Later, she became a lecturer at the University of Halabja 📚, teaching Calculus, scientific debate, atomic labs, metrology, and electricity & magnetism between 2014 and 2018. Currently, she continues her academic journey as a Quantum Mechanics professor ⚛️ for third-year students at the University of Halabja, contributing to the next generation of physicists. 🚀

Research Experience

Ms. Ala Hssain 🎓 is proficient in advanced computational tools for molecular simulations and density functional theory (DFT) 🔬. She has expertise in Gaussian software for molecular modeling, enabling precise quantum mechanical calculations ⚛️. Additionally, she is skilled in VESTA for 3D visualization of crystal structures 🏗️, VMD for molecular dynamics simulations 🧬, Multiwfn for wavefunction analysis 🌊, and Siesta for efficient DFT calculations on complex materials 🏢. Her expertise in these tools enhances her research in material science, quantum mechanics, and computational physics, contributing to innovative advancements in the field. 🚀

Academic Activities

Ms. Ala Hssain 🎓 has an extensive research portfolio, focusing on material science, quantum mechanics, and computational chemistry 🔬. Her publications explore hydroxyapatite co-doping, spinel synthesis, and optoelectronic compounds. Notable works include DFT modeling of Secnidazole 🧪, structural and spectroscopic studies on serotonin ⚛️, and Mg-doped Zn-based hydroxyapatites 🏗️. She has also contributed to theoretical and experimental research on L-tryptophan dimers 🧬. Published in prestigious journals like Chemical Physics Letters and Journal of Molecular Structure, her studies drive advancements in materials chemistry, nanotechnology, and molecular simulations. 🚀📖

Research Focus

Ms. Ala Hssain’s research focuses on Computational and Experimental Chemistry 🧪, particularly in the structural and spectroscopic analysis of biomolecules. Her work on the L-tryptophan dimer state involves a combination of Density Functional Theory (DFT)🖥️ and Molecular Dynamics (MD) simulations to understand molecular interactions and stability. This interdisciplinary research bridges theoretical modeling and experimental validation, contributing to fields like biophysics 🧬, pharmaceutical sciences 💊, and material chemistry 🔬. Her expertise lies in using computational tools to predict molecular behavior, aiding in drug design and biomolecular engineering. Her findings enhance the understanding of amino acid interactions in biological systems.

Publication Top Notes

Structural and spectroscopic study of L-tryptophan dimer state using DFT and MD: Computational and experimental analysis